Ion Beam Applications (XBRU:IBAS) EBIT : €4.92 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Ion Beam Applications EBIT?

Ion Beam Applications's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was €21.23 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was €4.92 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ion Beam Applications's annualized ROC % for the quarter that ended in Dec. 2023 was 8.74%. Ion Beam Applications's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 87.75%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ion Beam Applications's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 0.32%.

Ion Beam Applications EBIT Historical Data

The historical data trend for Ion Beam Applications's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ion Beam Applications EBIT Chart

Ion Beam Applications Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

13.25

35.84

10.77

1.63

4.92

Ion Beam Applications Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															8.50	3.43	-1.81	-16.31	21.23

Competitive Comparison of Ion Beam Applications's EBIT

For the Medical Devices subindustry, Ion Beam Applications's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ion Beam Applications's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's EV-to-EBIT falls into.

Ion Beam Applications EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4.92 Mil.

Ion Beam Applications (XBRU:IBAS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ion Beam Applications's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	51.7 * ( 1 - 18.75% )	/	( (510.168	+	450.883)	/ 2 )
=	42.00625	/	480.5255
=	8.74 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	610.241	-	95.114	-	( 115.251	-	max(0, 478.044	-	483.003	+	115.251	))
=	510.168

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	597.528	-	147.201	-	( 109.306	-	max(0, 452.601	-	452.045	+	109.306	))
=	450.883

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Ion Beam Applications's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	42.46	/	( ( (47.313 + max(-100.735, 0))	+	(49.465 + max(-97.289, 0)) )	/	2 )
=	42.46	/	( ( 47.313	+	49.465 )	/	2 )
=	42.46	/	48.389
=	87.75 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(93.728	+	133.819	+	140.205)	-	(95.114	+	0	+	373.373)
=	-100.735

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(107.576	+	130.545	+	104.618)	-	(147.201	+	0	+	292.827)
=	-97.289

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ion Beam Applications's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	4.923	/	1556.005
	=	0.32 %

Ion Beam Applications EBIT Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ion Beam Applications (XBRU:IBAS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (XBRU:IBAS) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

IOBCF:USA 0GZK:UK IOB:Germany IBAB:Belgium

Address

Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348

Website

https://www.iba-worldwide.com

Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.

Ion Beam Applications (XBRU:IBAS) Headlines

No Headlines